Laurion Capital Management LP Pyxis Oncology, Inc. Call Options Transaction History
Laurion Capital Management LP
- $5.23 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PYXS
# of Institutions
99Shares Held
24.3MCall Options Held
993KPut Options Held
42.6K-
Israel Englander Millennium Management LLC | New York, Ny2.98MShares$4.05 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.79MShares$3.79 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.44MShares$3.32 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.08MShares$1.47 Million0.0% of portfolio
-
Palo Alto Investors LP Palo Alto, CA1.04MShares$1.41 Million0.26% of portfolio
About Pyxis Oncology, Inc.
- Ticker PYXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,096,400
- Market Cap $47.7M
- Description
- Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...